Related Experiment Video
Updated: Aug 7, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Apoptosis induction by epigallocatechin gallate involves its binding to Fas
S Hayakawa1, K Saeki, M Sazuka
1School of Food and Nutritional Sciences, University of Shizuoka, Yada, Shizuoka, 422-8526, Japan.
Abstract:
Epigallocatechin gallate (EGCG) is known to induce apoptosis in various types of tumor cells, but the precise mechanism by which EGCG induces apoptosis remains to be elucidated. The Fas-Fas ligand system is one of the major pathways operating in the apoptotic cascade. The aim of this study was to examine the possibility that EGCG-binding to Fas triggers the Fas-mediated apoptosis. The EGCG treatment of human monocytic leukemia U937 cells resulted in elevation of caspase 8 activity and fragmentation of caspase 8. The DNA ladder formation caused by the EGCG treatment was inhibited by the caspase 8 inhibitor. These findings suggested the involvement of the Fas-mediated cascade in the EGCG-induced apoptosis in U937 cells. Affinity chromatography revealed the binding between EGCG and Fas. Thus, the results suggest that EGCG-binding to Fas, presumably on the cell surface, triggers the Fas-mediated apoptosis in U937 cells.
Insights
Epigallocatechin gallate (EGCG) triggers cancer cell death by binding to Fas, activating the Fas-mediated apoptosis pathway. This mechanism involves caspase 8 activation and DNA fragmentation in leukemia cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Epigallocatechin gallate (EGCG) is a polyphenol with known anti-cancer properties, including the induction of apoptosis in tumor cells.
- The precise molecular mechanisms underlying EGCG-induced apoptosis are not fully understood.
- The Fas/Fas ligand system is a critical pathway in initiating programmed cell death (apoptosis).
Purpose of the Study:
- To investigate whether Epigallocatechin gallate (EGCG) binding to Fas can initiate Fas-mediated apoptosis.
- To elucidate the role of the Fas-mediated apoptotic cascade in EGCG's cytotoxic effects on cancer cells.
Main Methods:
- Human monocytic leukemia U937 cells were treated with EGCG.
- Caspase 8 activity and fragmentation were assessed.
- DNA ladder formation was analyzed, with and without a caspase 8 inhibitor.
- Affinity chromatography was employed to detect EGCG-Fas binding.
Main Results:
- EGCG treatment led to increased caspase 8 activity and fragmentation in U937 cells.
- The caspase 8 inhibitor blocked EGCG-induced DNA ladder formation, indicating caspase 8's role.
- Affinity chromatography confirmed direct binding between EGCG and Fas.
- These results suggest EGCG initiates apoptosis by interacting with Fas on the cell surface.
Conclusions:
- EGCG binding to Fas triggers the Fas-mediated apoptotic pathway in U937 leukemia cells.
- This interaction activates caspase 8, leading to DNA fragmentation and cell death.
- The findings provide a novel mechanistic insight into EGCG's anti-cancer activity.
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

